A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19

Clinical trial NCT03891420 · TERMINATED

Trial details

NCT number: NCT03891420
Sponsor: BioCryst Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

COVID-19 Yellow Fever

Start date: 2020-04-09
Primary completion: 2021-01-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.